Large-scale testing (Phase 3)Study completedNCT00236548
What this trial is testing
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection
Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1